Jeff Hunnicutt, CEO of Highlands Oncology Group, discusses the difference between business intelligence and artificial intelligence (AI), including process implementation and data compilation.
In this interview from the Association of Community Cancer Centers’ 49th Annual Meeting and Cancer Center Business Summit, Jeff Hunnicutt, CEO of Highlands Oncology Group, discusses the difference between business intelligence (BI) and artificial intelligence (AI), including process implementation and data compilation.
Transcript
Can you discuss what BI-enabled technology is and how it is used?
BI technology is business intelligence. Essentially, it's advanced internal analytics inside of your practice. Many applications that we deal with on a daily basis, we'll have kind of canned reports that will sit inside. They are useful inside of that application, but frequently, you want to be able to answer more difficult and advanced questions that involve multiple data sources. Business intelligence allows you to grab those data elements from different data sources, bring them into 1 platform, and then throw a visualization tool on top of that so that you can answer more complex questions and really be more efficient running your practice.
How does BI data analytics differ from AI, and what are the potential implications for oncology?
Compilation of data for business intelligence is a much easier endeavor than, say, [AI]. Now, AI is kind of an umbrella term where you have a lot of different technologies that sit underneath that, but the more advanced components of AI—things like deep learning—those take months, if not years, to even compile the amount of data and then have the engine ingest it and figure out what to do with it.
BI, you're gonna have an upfront lift of, say, interfacing technologies to get them into a central repository. But after that, it's really just running the reports and doing your analysis. I'd say it's significantly easier to get BI off the ground than a more complex AI model.
Using AI for the Medical Note: Game Changer or a Bridge Too Far?
July 9th 2025During the “Tech Innovations in Community Oncology” meeting from Tennessee Oncology, oncologists explore artificial intelligence (AI) tools like DeepScribe to enhance documentation efficiency, reduce burnout, and improve patient engagement in clinical settings.
Read More
Practical Considerations for AI in Community Oncology
July 8th 2025Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."
Read More
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More